The IRE1 RNase domain can also promote degradation of a subset of mRNAs/miRNAs in a process known as ‘regulated IRE1-dependent decay’ (RIDD) (16), which is a mechanism beginning to be understood in pathological settings including metabolism, inflammation and cancer (17–19). Here, ERN1 is linked to cancer.